News

20 September 2016

"Una inyección reduce la enfermedad de Huntington en ratones durante varios meses" (CRG / La Vanguardia.com)

20 September 2016

Strengthening gene therapy for Huntington’s disease

A single injection of a new treatment has reduced the activity of the gene responsible for Huntington’s disease for several months in a trial in mice.

15 September 2016

"The long-sought cure to Huntington's disease" (CRG / Cordis)

14 September 2016

The Science to Business (S2B) Concept Challenge fosters again the CRG entrepreneurial spirit

The second edition of the Science to Business (S2B) Concept Challenge is open and ready to receive new ideas...

8 September 2016

"The long-sought cure to Huntington's disease" (CRG / Research EU Results Magazine)

7 September 2016

Challenges and rewards of building a biotech

12/09/2016 09:45 CHARLES DARWIN Keynote talk in the in the context of the 3rd CRG BioBusiness School."Challenges and rewards of building a biotech"Marc Martinell, CEO and Founder at Minoryx Therapeutics
Find it out next Friday, September 12 at 09h45 by joining the session.

7 September 2016

Round-table: Why is this a good time to start your own company?

16/09/201610:00RAMON Y CAJAL
Find it out next Friday, September 16 at 10h00 by joining a round-table discussion with some of the most relevant members of our regional, as well as international ecosystem.

Expert panel

Alexandre Casta (Investment Manager at Caixa Capital Risk)
Oscar Flores (CEO and Founder of GenomCore)
Luis Ruiz (CEO at Spherium Biomed)
Leandro Vetcher (Associate Director of Business Development at Harvard OTD)

Chair

Pablo Cironi (Head TBDO-CRG)

The round table is open to all the PRBB community, and it takes place in the context of the 3rd CRG BioBusiness School to be held at CRG from 12-16 September 2016. For more details please check the WebPage http://tbdo.crg.eu/entrepreneurs/entrepreneurs-...